T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study.

Autor: Gainor JF; Massachusetts General Hospital, Boston, Massachusetts., Patel MR; Florida Cancer Specialists, Sarasota, Florida.; Sarah Cannon Research Institute, Nashville, Tennessee., Weber JS; Perlmutter Cancer Center at NYU Langone Health, New York, New York., Gutierrez M; Hackensack University Medical Center, Hackensack, New Jersey., Bauman JE; George Washington University Cancer Center, Washington, District of Columbia., Clarke JM; Duke University Medical Center, Durham, North Carolina., Julian R; University of Arizona Cancer Center, Tucson, Arizona., Scott AJ; University of Arizona Cancer Center, Tucson, Arizona., Geiger JL; The Cleveland Clinic Foundation, Cleveland, Ohio., Kirtane K; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Robert-Tissot C; Moderna, Inc., Cambridge, Massachusetts., Coder B; Moderna, Inc., Cambridge, Massachusetts., Tasneem M; Moderna, Inc., Cambridge, Massachusetts., Sun J; Moderna, Inc., Cambridge, Massachusetts., Zheng W; Moderna, Inc., Cambridge, Massachusetts., Gerbereux L; Moderna, Inc., Cambridge, Massachusetts., Laino A; Moderna, Inc., Cambridge, Massachusetts., Porichis F; Moderna, Inc., Cambridge, Massachusetts., Pollard JR; Moderna, Inc., Cambridge, Massachusetts., Hou P; Moderna, Inc., Cambridge, Massachusetts., Sehgal V; Moderna, Inc., Cambridge, Massachusetts., Chen X; Moderna, Inc., Cambridge, Massachusetts., Morrissey M; Moderna, Inc., Cambridge, Massachusetts., Daghestani HN; Moderna, Inc., Cambridge, Massachusetts., Feldman I; Moderna, Inc., Cambridge, Massachusetts., Srinivasan L; Moderna, Inc., Cambridge, Massachusetts., Frederick JP; Moderna, Inc., Cambridge, Massachusetts., Brown M; Moderna, Inc., Cambridge, Massachusetts., Aanur P; Moderna, Inc., Cambridge, Massachusetts., Meehan R; Moderna, Inc., Cambridge, Massachusetts., Burris HA 3rd; Sarah Cannon Research Institute, Nashville, Tennessee.

Publikováno v: Cancer discovery [Cancer Discov] 2024 Nov 01; Vol. 14 (11), pp. 2209-2223.

Häufigkeit problematischen Alkoholkonsums unter Allgemeinkrankenhauspatienten

Autor: Coder, B, Freyer-Adam, J, Bischof, G, Rumpf, HJ, John, U, Hapke, U

Publikováno v: Kongress Medizin und Gesellschaft 2007; 20070917-20070921; Augsburg; DOC07gmds057 /20070906/

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1175::76cd3b16943863552f2e7f87689937d8
http://www.egms.de/en/meetings/gmds2007/07gmds057.shtml

Eine Gesundheitsstudie am Arbeitsamt: Gesundheits- und Risikoverhalten sowie Bereitschaft zur Studienteilnahme unter Arbeitssuchenden

Autor: Coder, B, Pockrandt, C, Lau, K, Hartmann, B, John, U, Freyer-Adam, J

Publikováno v: Kongress Medizin und Gesellschaft 2007; 20070917-20070921; Augsburg; DOC07gmds056 /20070906/

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1175::d667bdd3b6b2b2a22416bd1f484369c5
http://www.egms.de/en/meetings/gmds2007/07gmds056.shtml

Documentation and coding of ED patient encounters: an evaluation of the accuracy of an electronic medical record

Autor: Silfen, Eric ^⁎

Publikováno v: In American Journal of Emergency Medicine 2006 24(6):664-678

The performance of two motivation measures and outcome after alcohol detoxification.

Autor: Freyer-Adam J, Coder B, Ottersbach C, Tonigan JS, Rumpf HJ, John U, Hapke U

Publikováno v: Alcohol & Alcoholism; Jan/Feb2009, Vol. 44 Issue 1, p77-83, 7p